초록

Bonded composites, and absorbent articles made with such bonded composites. The bonded composites have first and second thin-section elements bonded to each other by bonds defining a bond pattern.

대표청구항 ▼

Bonded composites, and absorbent articles made with such bonded composites. The bonded composites have first and second thin-section elements bonded to each other by bonds defining a bond pattern. Research, 15, (1995),pp. 873-878. Kelner, M.J., et al., "Nonresponsiveness of the Metastatic Human Lun

Bonded composites, and absorbent articles made with such bonded composites. The bonded composites have first and second thin-section elements bonded to each other by bonds defining a bond pattern. Research, 15, (1995),pp. 873-878. Kelner, M.J., et al., "Nonresponsiveness of the Metastatic Human Lung Carcinoma MV522 Xenograft to Conventional Anticancer Agents", Anticancer Research, 15, (1995), pp. 867-872. Kelner, M.J., et al., "Preclinical Evaluation of Illudens as Anticancer Agents", Cancer Research, 47, (1987), pp. 3186-3189. Kelner, M.J., et al., "Preclinical Evaluation of Illudens as Anticancer Agents: Basis for Selective Cytotoxicity", J. Natl. Cancer Inst., 82 (19), (1987), pp. 1562-1565. Lu, Jianliang, et al., "An expeditious synthesis of the potent antitumor agent, (+)-hydroxymethylacylfulvene using an allenic Paulson-Khand type cycloaddition", American Chemical Society, Division of Organic Chemistry Abstracts, 217th ACS National Meeting in Anaheim, CA,(Mar.21-25, 1999), 1 p. Matsumoto, Takeshi, et al., "An Alternative Synthesis of Illudin M", Tetrahedron Letters, 14, (Mar. 1970), pp. 1171-1174. Matsumoto, T., et al., "Synthesis of Illudin S", Tetrahedron Letters, 23, (May 1971), pp. 2049-2052. McMorris, T.C., et al., "(Hydroxymethyl) Acyfulvene: An Illuden Derivative with Superior Antitumor Properties", Journal of Natural Products, 59 (9), (Sep. 1996), pp. 896-899. McMorris, T.C., et al., "(Hydroxymethyl)acylfulvene: An Illudin Derivative with Superior Antitumor Properties", Chemical Abstracts, abstract No. 196032, vol. 125, No. 15, (Oct. 7, 1996). McMorris, T.C., et al., "Acylfulvenes, a New Class of Potent Antitumor Agents", Experientia, 52 (1), (Apr. 21, 1995), pp. 75-80. McMorris, Trevor C., et al., "An Acetal Derivative of Illudin S with Improved Antitumor Activity", Tetrahedron letters, 38 (10), (1997), pp. 1697-1698. McMorris, Trevor C., et al., "Design and Synthesis of Antitumor Acylfulvenes", The Journal of Organic Chemistry 62 (9), (1997), pp. 3015-3018. McMorris, T.C., et al., "Fungal Metabolites. The Structures of the Novel Sesquiterpenoids Illudin -S and -M", J. of Amer. Chem. Soc., 87 (7), (1965), pp. 1594-1600. McMorris, T.C., et al., "On the Mechanism of Toxicity of Illudens: The Role of Glutathione", Chemical Research Toxicology, 3 (6), (Nov./Dec. 1990), pp. 574-579. McMorris, T.C., et al., "Reaction of Antitumor Hydroxymethylacylfulvene (HMAF) with Thiols", Tetrahedron, 53 (43), (1997), pp. 14579-14590. McMorris, T.C., et al., "Structure and reactivity of Illudens", Tetrahedron, 45 (17), (1989), pp. 5433-5440. McMorris, T.C., et al., "Structure-Activity Relationships of Illudens: Analogs with Improved Therapeutic Index", Journal of Organic Chemistry, 57 (25), (Dec. 4, 1992), pp. 6876-6883. McMorris, Trevor C., et al., "Total Synthesis of hydroxymethylacylfulvene, an antitumour derivative of illudin S", Chem. Commun., (1997), pp. 315-316. Padwa, Albert, et al., "An approach toward the Illudin family of sesquiterpenes using the tandem cyclization-cycloaddition reaction of rhodium carbenoids", The Journal of Organic Chemistry, 62 (5), (Mar. 7, 1997), pp. 1317-1325. Padwa, Albert, et al., "Generation and Cycloaddition behavior of spirocyclic Carbonyl ylides. Application to the synthesis of the Pterosin Family of Sequiterpenes", The Journal of Organic Chemistry, 61 (1), (Jan. 12, 1996), pp. 73-81. Padwa, Albert, et al., "Synthetic studies toward Illudins and Ptaguilosin. A Highly Convergent approach via the dipolar cycloaddition of carbony ylides", The Journal of the American Chemical Society, 116, (1994), pp. 2667-2668. Schabel, F.M. et al., "Testing Therapeutic Hypotheses in Mice and Man:Observations on the Therapeutic Activity Against Advanced Solid Tumors of Mice Treated with Anticancer Drugs that Have Demonstrated or Potential Clinical Utility for Treatment of Advanced Solid Tumors of Man", In: Methods in Cancer Research, vol. XVII, Cancer Drug Development Part B, Chapter 1, Academic Press, Inc., (1979), pp. 3-50. Shimomura, O., "The Role of Superoxide Dismutase in Regulating the Light Emission of Luminescent Fungi", The Journal of Experimental Botany, 43 (256), (Nov. 199 2), pp. 1519-1525. Shinozawa, S., et al., "The Antitumor Effect of Illudin S (Lampterol) Entrapped in Liposome for Mice Inolculated with Ehrlich Ascites Tumor Cells", Chemical Abstracts, 90 (25), Abstract No. 197682m, (Jun. 18, 1979), 1 p. Steel, G.G., et al. "The Response to Chemotherapy of a Variety of Human Tumor Xenografts", Br. J. Cancer, 47, (1983), pp. 001-013. Tanaka, K., et al., "Metabolism by Rat Liver Cytosol of Illuden S, a Toxic Substance of Lampteromyces Japonicus. II. Characterization of Illuden S-Metabolizing Enzyme", Xenobiotica, 22 (1), (1992), pp. 33-39. Tanaka, K., et al., "Metabolism of Illuden S. a Toxic Principle of Lampteromyces Japonicus, by Rat Liver. I. Isolation and Identification of Cyclopropane Ring-Cleavage Metabolites", Xenobiotica, 20 (7), (1990), pp. 671-681. Tanaka, Ken, et al., "Michael-type addition of Illudin S, a toxic substance from Lampteromyces japonicus with Cysteine and Cysteine-containing peptides in vitro", Chem. Pharm. Bull., vol. 44, No. 2, (1996), pp. 273-279. Varki, N.M., et al., "Cloned Low Metastic Variants from Human Lung Carcinoma Metastases", Anticancer Research, 10, (1990), pp. 637-644. Vendetti, J.M., et al., "Current NCI Preclinical Antitumor Screening in Vivo: Results of Tumor Panel Screening, 1976-1982, and Future Directions", Advances in Pharmacology and Chemotherapy, 20, (1984), pp. 1-20. Venditti, J.M., "The National Cancer Institute Antitumor Drug Discovery Program, Current and Future Perspectives: A Commentary", Cancer Treatment Reports, 67 (9), (Sep. 1983), pp. 767-772. Walser, J., et al., "Mode of Action of Illuden S", Antimicrobial Agents and Chemotherapy, 3 (3), (Mar. 1973), pp. 357-363. Weinreb, S.M., "Fulvenes Derived from Illuden S", Tetrahedron Letters, 38, (Sep. 1971), pp. 3489-3491. Weiss, D., et al., "Antibiotic Substances from Basidiomycetes. VII. Clitocybe Illudens", Proc. Natl. Acad. Sci. USA, 36 (5), (1950), 300-305. "Current Results of the Screening Program at the Division of Cancer treatment, National Cancer Institute", Europ. J. Cancer, 17, (1981), pp. 129-142. Goldin, A., et al., "Historical Development and Current Strategy of the National Cancer Institute Drug Development Program", In: Methods in Cancer Research, vol. XVI, Cancer Drug Development Part A, Chapter V, Academic Press, Inc., New York, (1979), pp. 165-245. Greene, T.W., Protective Groups in Organic Synthesis, Chapters 4, 5 & 6, John Wiley & Sons, Inc., New York,(1981), pp. 114-217. Hanson, J.R., et al., "Studies in Terpenoid Biosynthesis. Part XV. Biosynthesis of the Sesquiterpenoid Illuden M", Journal of the Chemical Society, Perkin Transactions I, (1976), pp. 876-880. Hara, M., et al., "6-Deoxyilludin M, a New Antitumor Antibiotic: Fermentation, Isolation and Structural Identification", The Journal of Antibiotics, 40, (Nov. 1987), pp. 1643-1646. Harttig, U., et al., "Leaianafulvene, a Sesquiterpenoid Fulvene Derivative from Cultures of Mycena Leaiana", Phytochemistry, 29 (12), (1990), pp. 3942-3944. Hirono, I., et al., "Reproduction of Acute Braken Poisoning in a Calf with Ptaquiloside, a Bracken Constituent", The Veterinary Record, 115 (15), (Oct. 1984), pp. 375-378. Inoue, K., et al., "Antitumor Efficacy of Seventeen Anticancer Drugs in Human Breast Cancer Xenograft (MX-1) Transplanted in Nude Mice", Cancer Chemother. Pharamacol., 10, (1983), pp. 182-186. Kawato, Y., et al., "Antitumor Activity of a Camptothecin Derivative, CPT-11, Against Human Tumor Xenografts in Nude Mice", Cancer Chemother. Pharmacol., 28, (1991), pp. 192-198. Kelner, M.J., et al., "In Vitro and In Vivo Studies on the Anticancer Activity of Dehydroilluden M", Anticancer Research, 15, (1995),pp. 873-878. Kelner, M.J., et al., "Nonresponsiveness of the Metastatic Human Lung Carcinoma MV522 Xenograft to Conventional Anticancer Agents", Anticancer Research, 15, (1995), pp. 867-872. Ke